Posted on January 24, 2022
By Alexander M. Haydl | Boehringer Ingelheim Germany, Head of Late-Stage Development Laboratory and Product Owner of Digital Process Development
January 28, 2022
By Stuart Flanagan | Evotec, Group Leader
It is often said that an organisation is only as strong as the people who work within it. But what does “strong” mean in this context? To me, “strong” means empowered, passionate, dedicated and extraordinary. And you will certainly find a lot of empowered, passionate, dedicated and extraordinary people at Evotec. Running through the veins […]
January 4, 2022
By Rebekah Martin | AstraZeneca, Senior Vice President of Reward and Inclusion
November 17, 2021
By Bo Quan Tan | Lonza Singapore, Manager of Project Engineering Department
February 23, 2022
By Jürgen Schrapp | Bayer, Head of R&D Procurement
January 11, 2022
By Jennifer Snyder | Novartis Pharmaceuticals, Director, Portfolio Strategy Management for Technical Research and Development Cell & Gene Therapy
June 8, 2021
By Carolyn Carroll | SwanBio Theraputics, Chief People Officer, Winners of 2021 Life Sciences Pennsylvania Emerging Company of the Year
December 7, 2022
By Ahmed Elhusseiny | Roche Pharmaceuticals, Area Head, Asia Pacific
March 7, 2022
By Vijetha Bhat | Lonza, Houston,Texas, Scientist, Research and Development
June 24, 2021
By Francis Van Parys | Cytiva, Vice President Commercial Asia Pacific
May 20, 2022
By Jason Rudd | Amgen, Statistical Programming Manager
August 19, 2021
By Galym Dauletbakov | Takeda, Business Operations Head UCC
March 10, 2022
By Elizabeth Jurica | Bristol Myers Squibb, Principal Scientist
August 31, 2021
By Teresa Foy | Bristol Myers Squibb, Sr Vice President Immuno-Oncology and Cellular Therapy
